1O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating turnout growth in immunodeficient mice. Nature, 2007,445 : 106-110.
2Ma S,Chan KW, Hu L, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology, 2007,132: 2542-2556.
3Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res, 2007,67:1030-1037.
4Prince ME, Sivanandan R, Kaezorowski A,et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proe Natl Acad Sci USA,2007,104: 973-978.
5Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells: Perspectives on current status and future directions-AACR Workshop on cancer stem cells. Cancer Res,2006,66:9339-9344.
6Karnangar F, Dawsey SM, Blaser MJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst,2006,98:1445- 1452.
7Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology, 2007,133 : 659-672.
8Matsumoto Y, Marusawa H, Kinoshita K, et al. Helicobacter pylori infection triggers aberrant expression of activa- tion induced cytidine deaminase in gastric epithelium. Nat Med, 2007, 13 : 470- 476.
9Osawa M, Hanada K. Hamada H, et al. Longterm lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell, Science, 1996, 273 : 242-245.
10Goodell MA, Rosenzweig M, Kim H, et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med, 1997, 3: 1337-1345.
3Choi HS, Kim WT, Ryu CJ. Antibody approaches to prepare clinically transplantable cells from human embryonic stem cells: identification of human embryonic stem cell surface markers by monoclonal antibodies. Biotechnol J. 2014;9(7): 915-920.
4Zhu L, Ruan Z, Yin Y, et al. Expression and significance of DLL4--Notch signaling pathway in the differentiation of human umbilical cord derived mesenchymal stem cells into cardiomyocytes induced by 5-azacytidine. Cell Biochem Biophys. 2015;71(1):249-253.
5Dhanasekaran M, Indumathi S, Kanmani A, et al. Surface antigenic profiling of stem cells from human omentum fat in comparison with subcutaneous fat and bone marrow. Cvtotechnoloav. 2012:64(5):497-509.
6Andrews TE, Wang D, Harki DA. Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery. Drug Deliv Transl Res. 2013;3(2):121-142.
7Mohsen-Kanson T, HafnerAL, Wdziekonski B, et al. Expression of cell surface markers during self-renewal and differentiation of human adipose-derived stem ceils. Biochem Biophys Res Commun. 2013;430(3):871-875.
8Biddle A, Gammon L, Fazil B, et al. CD44 staining of cancer stem-like cells is influenced by down-regulation of CD44 variant isoforms and up-regulation of the standard CD44 isoform in the population of cells that have undergone epithelial-to-mesenchymal transition. PLoS One. 2013;8(2): e57314.
9Hiscox S, Baruha B, Smith C, et al. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan. BMC Cancer. 2012 Oct 6;12:458.
10Gisina AM, Lupatov AY, Karalkin PA, et al. Subpopulation of colorectal adenocarcinoma cells co-expressing CD133 and cancer stem cells markers of other tumors. Bull Exp Biol Med. 2012; 152(6):739-742.
